AHCO
Income statement / Annual
Last year (2024), AdaptHealth Corp.'s total revenue was $3.26 B,
an increase of 1.90% from the previous year.
In 2024, AdaptHealth Corp.'s net income was $90.42 M.
See AdaptHealth Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.26 B |
$3.20 B |
$2.97 B |
$2.45 B |
$1.06 B |
$529.64 M |
$345.28 M |
$192.56 M |
$174.32 M |
| Cost of Revenue |
$2.58 B
|
$2.52 B
|
$2.55 B
|
$2.01 B
|
$898.60 M
|
$440.71 M
|
$285.20 M
|
$162.90 M
|
$158.69 M
|
| Gross Profit |
$681.09 M
|
$681.77 M
|
$417.43 M
|
$445.61 M
|
$157.79 M
|
$88.94 M
|
$60.08 M
|
$29.66 M
|
$15.63 M
|
| Gross Profit Ratio |
0.21
|
0.21
|
0.14
|
0.18
|
0.15
|
0.17
|
0.17
|
0.15
|
0.09
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$310.00 K
|
$0.00
|
| General & Administrative Expenses |
$359.24 M
|
$190.09 M
|
$162.13 M
|
$167.51 M
|
$89.35 M
|
$56.49 M
|
$1.04 M
|
$9.00 M
|
$8.00 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$482.74 K
|
$399.23 K
|
| Selling, General & Administrative Expenses |
$359.24 M
|
$190.09 M
|
$162.13 M
|
$167.51 M
|
$89.35 M
|
$56.49 M
|
$1.04 M
|
$693.00
|
$11.40 M
|
| Other Expenses |
$58.12 M
|
$1.09 B
|
$64.89 M
|
$52.50 M
|
-$2.90 M
|
$3.07 M
|
$197.59 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$417.36 M
|
$1.28 B
|
$227.02 M
|
$220.01 M
|
$86.44 M
|
$59.56 M
|
$1.23 M
|
$693.00
|
$13.30 M
|
| Cost And Expenses |
$3.00 B
|
$3.80 B
|
$2.78 B
|
$2.23 B
|
$985.04 M
|
$500.27 M
|
$1.23 M
|
$693.00
|
$171.99 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.15 M
|
$0.00
|
$5.76 M
|
| Interest Expense |
$126.67 M
|
$130.30 M
|
$109.41 M
|
$95.20 M
|
$41.43 M
|
$39.30 M
|
$4.15 M
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$365.33 M
|
$420.59 M
|
$423.44 M
|
$258.05 M
|
$82.45 M
|
$62.57 M
|
$50.61 M
|
$27.82 M
|
$26.56 M
|
| EBITDA |
$628.02 M |
-$171.09 M |
$630.76 M |
$544.21 M |
-$82.17 M |
$80.01 M |
$80.85 M |
$43.90 M |
$28.89 M |
| EBITDA Ratio |
0.19
|
-0.05
|
0.21
|
0.22
|
-0.08
|
0.15
|
0.23
|
0.23
|
0.17
|
| Operating Income Ratio |
0.08
|
-0.19
|
0.06
|
0.09
|
0.07
|
0.06
|
-0
|
-0
|
0.01
|
| Total Other Income/Expenses Net |
-$127.71 M
|
-$125.38 M
|
-$92.51 M
|
-$34.65 M
|
-$277.39 M
|
-$51.24 M
|
-$8.85 M
|
$0.00
|
-$5.76 M
|
| Income Before Tax |
$136.02 M
|
-$723.78 M
|
$97.90 M
|
$190.96 M
|
-$206.04 M
|
-$21.86 M
|
$2.92 M
|
-$693.00
|
-$3.44 M
|
| Income Before Tax Ratio |
0.04
|
-0.23
|
0.03
|
0.08
|
-0.2
|
-0.04
|
0.01
|
-0
|
-0.02
|
| Income Tax Expense |
$41.24 M
|
-$49.00 M
|
$24.77 M
|
$32.81 M
|
-$11.96 M
|
$739.00 K
|
$829.81 K
|
$0.00
|
-$208.45 K
|
| Net Income |
$90.42 M
|
-$678.90 M
|
$69.32 M
|
$156.18 M
|
-$161.63 M
|
-$21.34 M
|
$2.09 M
|
-$693.00
|
-$3.79 M
|
| Net Income Ratio |
0.03
|
-0.21
|
0.02
|
0.06
|
-0.15
|
-0.04
|
0.01
|
-0
|
-0.02
|
| EPS |
0.62 |
-5.32 |
0.52 |
1.12 |
-1.23 |
0.17 |
0.0668 |
-2.2176E-5 |
-0.121 |
| EPS Diluted |
0.61 |
-5.31 |
0.5 |
0.67 |
-1.23 |
0.17 |
0.0668 |
-2.2176E-5 |
-0.121 |
| Weighted Average Shares Out |
$133.76 M
|
$134.16 M
|
$134.18 M
|
$126.31 M
|
$52.49 M
|
$72.38 M
|
$31.25 M
|
$31.25 M
|
$31.25 M
|
| Weighted Average Shares Out Diluted |
$135.53 M
|
$134.42 M
|
$138.99 M
|
$133.03 M
|
$52.49 M
|
$72.38 M
|
$31.25 M
|
$31.25 M
|
$31.25 M
|
| Link |
|
|
|
|
|
|
|
|
|
